Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-48654
Sorrentino, S A; Doerries, C; Manes, C; Speer, T; Dessy, C; Lobysheva, I; Mohmand, W; Akbar, R; Bahlmann, F; Besler, C; Schaefer, A; Hilfiker-Kleiner, D; Lüscher, T F; Balligand, J L; Drexler, H; Landmesser, U (2011). Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional β1-blockade. Journal of the American College of Cardiology, 57(5):601-611.
| Published Version PDF - Registered users only 1979Kb | ||
| Accepted Version 249Kb |
Abstract
Nebivolol improves LV dysfunction and survival early after MI likely beyond the effects provided by conventional β₁-receptor blockade. Nebivolol induced effects on NO-mediated endothelial function, early endothelial progenitor cells and inhibition of myocardial NADPH oxidase likely contribute to these beneficial effects of nebivolol early after MI.
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Institute of Physiology 07 Faculty of Science > Institute of Physiology 04 Faculty of Medicine > Center for Integrative Human Physiology 04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiology |
| DDC: | 570 Life sciences; biology 610 Medicine & health |
| Language: | English |
| Date: | 2011 |
| Deposited On: | 14 Jul 2011 10:37 |
| Last Modified: | 23 Nov 2012 13:26 |
| Publisher: | Elsevier |
| ISSN: | 0735-1097 |
| Publisher DOI: | 10.1016/j.jacc.2010.09.037 |
| PubMed ID: | 21272752 |
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page